ArticleThe World Allergy Organization journal2009
Sub-lingual immunotherapy: world allergy organization position paper 2009.
Article in The World Allergy Organization journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Pooled it
- Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure.Allergy · 2014Pooled it
- A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis.BMC medicine · 2014Pooled it
- Negative clinical results from a randomised, double-blind, placebo-controlled trial evaluating the efficacy of two doses of immunologically enhanced, grass subcutaneous immunotherapy despite dose-dependent immunological response.Clinical drug investigation · 2014Trial
- World Allergy Organization Sublingual Immunotherapy Position Paper: 2026 update:The World Allergy Organization journal · 2026Review
- Real-Life Safety of Japanese Cedar Pollen Sublingual Immunotherapy Tablets: A Post-Marketing Survey.Clinical and translational allergy · 2026Article
- Comparative clinical efficacy and immunological modulation of subcutaneous vs. sublingual allergen immunotherapy in children with house dust mite-induced allergic asthma: a retrospective cohort study.Frontiers in medicine · 2026Article
- Improvement in nasal signs and eosinophils following 3 years of sublingual immunotherapy for allergic rhinitis.Frontiers in immunology · 2026Article
- Using mobile technology to increase adherence to sublingual immunotherapy: Real-world study with a new app/web platform AllergyVax®.The World Allergy Organization journal · 2025Article
- Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis.The journal of allergy and clinical immunology. Global · 2023Article
- Adherence in allergen immunotherapy: Current situation and future implications.Allergologie select · 2022Review
- Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: A systematic review and meta-analysis.Clinical and translational allergy · 2021Review
- Article
- Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis.Clinical and translational allergy · 2020Article
- Development of the BELANA questionnaire for the analysis of economic burdens of food allergy and intolerance.Allergologie select · 2018Article
- CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2018Review
- Chinese Guideline on allergen immunotherapy for allergic rhinitis.Journal of thoracic disease · 2017Review
- Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract.Current allergy and asthma reports · 2017Review
- [Adherence in specific immunotherapy].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2017Review
- Effectiveness of Specific Sublingual Immunotherapy in Korean Patients with Atopic Dermatitis.Annals of dermatology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.